BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7137196)

  • 1. Pharmaceutical manufacturer's responses to drug information inquiries.
    Bainbridge CV; D'Ambrosio GG; Petrick RJ; Weiss EM
    Am J Hosp Pharm; 1982 Sep; 39(9):1532-4. PubMed ID: 7137196
    [No Abstract]   [Full Text] [Related]  

  • 2. Bristol-Myers Squibb drug information department services.
    Sylvan L; Palmer-Shevlin N
    Hosp Pharm; 1995 Jan; 30(1):38-9, 44. PubMed ID: 10139729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a pharmacist on the educational value of pharmaceutical industry film showings.
    Bayliff CD; Edington RD; Johnston LJ; Shaw PW; Bailey DG
    Can J Hosp Pharm; 1991 Dec; 44(6):283-7. PubMed ID: 10116487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Educating physicians in the use of pharmaceuticals.
    Kaplan NM
    Circulation; 1985 Aug; 72(2 Pt 2):I31-5. PubMed ID: 4006155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physicians and pharmacists should cooperate more and more! It is beneficial for independent drug information].
    Nilsson JL
    Lakartidningen; 1996 Apr; 93(16):1507-8. PubMed ID: 8667740
    [No Abstract]   [Full Text] [Related]  

  • 6. Physician acquisition of prescription drug information.
    Evans KR; Beltramini RF
    J Health Care Mark; 1986 Dec; 6(4):15-25. PubMed ID: 10280368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of physicians toward formularies and services provided by pharmacists.
    Sansgiry SS; Hayes JD; Rice GK
    Manag Care Interface; 2003 Feb; 16(2):34-8. PubMed ID: 12647524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing drug information to health professionals and consumers: role and responsibility of the pharmaceutical manufacturer.
    Boyland JI
    Hosp Pharm; 1983 Apr; 18(4):211-3, 216. PubMed ID: 10260207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital pharmacists' attitudes towards medical services representatives: a comparison of directors, staff, and clinical pharmacists.
    McGhan W; Seery S; Hill B; Koda R
    Hosp Formul; 1982 Jul; 17(7):957-61. PubMed ID: 10256042
    [No Abstract]   [Full Text] [Related]  

  • 10. Information responsibilities of generic drug companies.
    Cramer R
    Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098
    [No Abstract]   [Full Text] [Related]  

  • 11. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
    Willig SH
    Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
    Barton L
    J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Career expectations of pharmacists with postgraduate training in drug information.
    Beckwith C; Tyler LS
    Am J Hosp Pharm; 1994 May; 51(9):1197-201. PubMed ID: 8042639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nursing home consultant pharmacists: drug information services, opinions, and activity study.
    Evens RP; Guernsey BG; Hightower WL
    Hosp Formul; 1982 Mar; 17(3):408-11, 418-20. PubMed ID: 10254880
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of attitudes, normative beliefs, and situational variables on physicians' use of pharmacists as drug information consultants.
    Fisher DJ; Pathak DS
    Am J Hosp Pharm; 1980 Apr; 37(4):483-91. PubMed ID: 7377210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug information: the pharmaceutical manufacturer's viewpoint and involvement.
    Meadows RJ
    Drug Inf J; 1977; 11(4):221-4. PubMed ID: 10307453
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in physicians' sources of pharmaceutical information: a review and analysis.
    Williams JR; Hensel PJ
    J Health Care Mark; 1991 Sep; 11(3):46-60. PubMed ID: 10120930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.